Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does DOLUTEGRAVIR Cause Immunodeficiency? 183 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 183 reports of Immunodeficiency have been filed in association with DOLUTEGRAVIR (Juluca). This represents 1.7% of all adverse event reports for DOLUTEGRAVIR.

183
Reports of Immunodeficiency with DOLUTEGRAVIR
1.7%
of all DOLUTEGRAVIR reports
101
Deaths
11
Hospitalizations

How Dangerous Is Immunodeficiency From DOLUTEGRAVIR?

Of the 183 reports, 101 (55.2%) resulted in death, 11 (6.0%) required hospitalization, and 2 (1.1%) were considered life-threatening.

Is Immunodeficiency Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for DOLUTEGRAVIR. However, 183 reports have been filed with the FAERS database.

What Other Side Effects Does DOLUTEGRAVIR Cause?

Foetal exposure during pregnancy (1,036) Exposure during pregnancy (776) Virologic failure (770) Pathogen resistance (586) Maternal exposure during pregnancy (517) Viral mutation identified (510) Treatment failure (453) Drug ineffective (447) Off label use (413) Blood hiv rna increased (410)

What Other Drugs Cause Immunodeficiency?

ADALIMUMAB (2,981) RITUXIMAB (1,256) TOCILIZUMAB (1,061) ABATACEPT (1,042) METHOTREXATE (926) ETANERCEPT (799) INFLIXIMAB (693) CETIRIZINE (650) METHYLPREDNISOLONE (615) ALBUTEROL (599)

Which DOLUTEGRAVIR Alternatives Have Lower Immunodeficiency Risk?

DOLUTEGRAVIR vs DOLUTEGRAVIR\LAMIVUDINE DOLUTEGRAVIR vs DOLUTEGRAVIR\LAMIVUDINE\TENOFOVIR DISOPROXIL DOLUTEGRAVIR vs DOLUTEGRAVIR\RILPIVIRINE DOLUTEGRAVIR vs DOMPERIDONE DOLUTEGRAVIR vs DOMPERIDONE\PANTOPRAZOLE

Related Pages

DOLUTEGRAVIR Full Profile All Immunodeficiency Reports All Drugs Causing Immunodeficiency DOLUTEGRAVIR Demographics